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Part 1: Structural Characterization and Computational Analysis of PDZ domains in Monosiga brevicollis
(Adapted from Gao et al. 2020. Protein Sci.)
Abstract
Identification of the molecular networks that facilitated the evolution of multicellular animals from their
unicellular ancestors is a fundamental problem in evolutionary cellular biology. Choanoflagellates are recognized
as the closest extant non-metazoan ancestors to animals. These unicellular eukaryotes can adopt a multicellularlike “rosette” state. Therefore, they are compelling models for the study of early multicellularity. Comparative
studies revealed that a number of putative human orthologs are present in choanoflagellate genomes, suggesting
that a subset of these genes were necessary for the emergence of multicellularity. However, previous work is
largely based on sequence alignments alone, which does not confirm structural nor functional similarity. Here,
we focus on the PDZ domain, a peptide-binding domain which plays critical roles in myriad cellular signaling
networks and which underwent a gene family expansion in metazoan lineages. Using a customized sequence
similarity search algorithm, we identified 178 PDZ domains in the Monosiga brevicollis proteome. This includes
11 previously unidentified sequences, which we analyzed using Rosetta and homology modeling. To assess
conservation of protein structure, we solved high resolution crystal structures of representative M. brevicollis
PDZ domains that are homologous to human GIPC and SHANK1 PDZ domains. To assess functional
conservation, we calculated binding affinities for mbGIPC, mbSHANK and mbSNX27 PDZ domains from M.
brevicollis. We find that peptide selectivity is generally conserved between these two disparate organisms.
Overall, our results provide novel insight into signaling pathways in a choanoflagellate model of primitive
multicellularity.
Introduction

The events in molecular evolution that led to the origination of multicellular eukaryotes are preserved in
the genomes of choanoflagellates, and they are recognized as the closest living relatives to the common ancestor
of metazoans and unicellular eukaryotes.1,2 Of particular interest in evolutionary cellular biology is the ability of
choanoflagellates to adopt a primitive multicellular state, known as a rosette.3–5 Comparative studies have
revealed that several human gene families have clear orthologs in the choanoflagellate clade, and many of these
orthologous genes are differentially expressed during development of the rosette.6 Furthermore, over 350 gene
families previously thought to be present only in animal lineages exist in choanoflagellate genomes.6 Therefore,
there is interest in understanding the molecular underpinnings of signaling pathway proteins in choanoflagellates,
in order to gain insight into how multicellularity emerged. Investigators have identified a multitude of conserved
protein structural domains and architectures in the choanoflagellate proteome that are essential to metazoan
intracellular signaling systems and development. Some examples include the Notch receptor, kinases (e.g., Src
family kinases, CamKII, etc.), ubiquitin ligases (e.g., Cbl), and PDZ domains, amongst others.2,7–11 Notably,
although functionally present, mechanisms of regulation can vary dramatically; while the phosphorylationdependent regulation of Cbl is conserved in metazoans and choanoflagellates, the allosteric regulation of the SH3SH2-Kinase module of Src family kinases is distinct.9,12,13
Of the shared gene families in metazoans and choanoflagellates, the PDZ domain is particularly interesting
for a number of reasons. PDZ domains play key functional roles in neuronal signaling, and the intercellular

attachments that are formed during rosette development are reminiscent of neuronal synapses.4,14–16 In addition,
PDZ domains are overrepresented in the genome of choanoflagellate Monosiga brevicollis relative to the
unicellular eukaryote Saccharomyces pombe.2 Finally, PDZ domains are known to have proliferated in the
metazoan lineage.16–19 Collectively, these data suggest that PDZ domains played an important role in the evolution
of multicellularity and that further characterization of PDZ domains in choanoflagellates may yield insights into
molecular mechanisms that facilitated primitive multicellular development. PDZ domains were named after the
first PDZ domain-containing proteins that were identified (PSD-95, Dlg1, and ZO-1).20–24 These initially
discovered PDZ domains all contain a “GLGF” amino acid sequence. This shared sequence, referred to as the
GLGF-loop, or the carboxylate-binding loop, comprises a key component of the canonical PDZ domain structure.
The well-conserved PDZ domain structure dictates its function in mediating protein-protein interactions.
Specifically, the amide nitrogen atoms in the backbone of the GLGF-loop directly interact with the carboxylate
atoms of the extreme C-terminus of a protein ligand.25,26 PDZ domains are approximately 80-100 residues in
length, and comparative analysis of hundreds of PDZ structures in the Protein Data Bank reveals a conserved
structural fold, consisting of a core antiparallel b-sheet and 1-2 a-helices (Figure 1).26–32
PDZ domains are scaffolding domains that bind target
proteins. In some instances, this facilitates localization of target
proteins within close proximity of auxiliary enzymatic domains on
the same polypeptide. In other instances, PDZ domain scaffolding
activity functions to mediate protein trafficking, and impacts
cellular signaling pathways. These PDZ domain interactions can
be modulated by other protein-protein interaction domains on the
same polypeptide, or in trans, by other proteins in larger Figure 1. Conserved fold of PDZ domain
macromolecular complexes.26,33,34 An example of the scaffolding structures. The human PDZ homologues of the
M. brevicollis PDZ domains studied in this paper
function of PDZ domains is the postsynaptic density of neurons, are shown in cartoon representation, colored by
where multiple receptor signaling networks are brought into close conserved secondary structure elements, as
physical proximity due to a number of PDZ domain-mediated labeled. Bound peptides are in black stick and
labeled.
interactions.35 As mentioned previously, an expansion of the
number of PDZ domain-containing genes coincided with the emergence of animal multicellularity.17 This
suggests that PDZ domains played a critical role in the evolution of multicellular animals. The human proteome
contains 272 PDZ domains in a variety of protein architectures, but all PDZ domains share the same basic
biochemical function of scaffolding protein-protein interactions.
Considering the importance of PDZ domains in a number of cellular processes, significant effort has been
invested in characterizing their peptide-binding selectivity. These domains bind to short sequences in target
proteins, often interacting with only 6 amino acid residues. In fact, the motifs of classically determined PDZ
binding classes are dependent on only two residues, the extreme C-terminal residue, termed P0 and two residues
adjacent, or P-2.26 For example, Class I PDZ domains recognize the motif X-S/T-X- f at the C-terminus of target
proteins (where X=any amino acid and f=any hydrophobic amino acid).26 Work in the last 10+ years using high
throughput techniques, e.g., phage display, peptide array, or the hold-up assay, has shifted this classical view of
PDZ domain binding to appreciate the importance of binding interactions at non-motif residues in the peptidebinding cleft.36–38 In addition, a number of elegant studies using directed evolution, or other protein engineering
techniques, have successfully identified structural elements that determine PDZ selectivity -- often through only
a small number of amino acid substitutions or post-translational modifications.39–43
The elucidation of PDZ binding selectivity has enabled investigators to trace the evolution of PDZ
specificity throughout the tree of life, including in bacteria, yeast, and plants.18,42,44 However, what remains to be

determined is whether or not the selectivity determinants in PDZ domains related by evolution are also conserved,
despite different signaling pathways, e.g., in uni- versus multicellular organisms, or those with and without a
nervous system. Previous work looking at the evolution of PDZ domains found that six amino acid positions
determine lineage relationships amongst 40,000 PDZ domains in 40 proteomes and that four of these positions
are in direct contact with non-motif peptide residues (P-1 and P-3).16 This result suggests that homologous proteins
will share conserved residues in the peptide-binding cleft, including those amino acids that directly interact with
residues beyond the P0 and P-2 motif positions.
In order to investigate these questions on a molecular level, we crystallized and solved four total structures
of two PDZ domains from the choanoflagellate, Monosiga brevicollis, including homologues of PDZ domains
from the human proteins GIPC1 and SHANK1 (Figure 1). We also investigated the binding affinities of a
homologue of human SNX27 (Figure 1). These proteins are important in postsynaptic signaling and wellconserved in M. brevicollis, despite over 200 million years of evolution between the last common ancestor of
humans and choanoflagellates -- and the emergence of neurons.35,45–47 Structural and binding affinity analyses
confirm that the residues in the peptide-binding clefts are generally conserved in these proteins. Previous studies
investigated the molecular basis of evolution, expansion, and rewiring in PDZ domain networks; however, here
we find that for closely related PDZ domains, selectivity determinants for all residues in the binding cleft are
generally conserved in evolution, despite a lack of conservation in shared target proteins.48,49
Results
Structural and biochemical characterization of mbGIPC PDZ
To determine if residues that directly interact with the ligand are conserved, including all of those within
the peptide-binding cleft of Class I PDZ domains, we set out to characterize a number of PDZ domains from
Monosiga brevicollis with clear homology to human PDZ proteins. We first chose to investigate the homolog of
the human GAIP interacting protein, C terminus, or GIPC.50 GIPC was first identified as an interactor of the Galpha interacting protein (GAIP), but was quickly shown to also interact directly with G-protein coupled receptors,
as well as dopamine and NMDA receptors in excitatory synapses of the central nervous system.47,50–52 Thus, GIPC
is important for both G-protein coupled receptor (GPCR) and neuronal signaling in human cells, and additional
studies have shown that it broadly regulates vesicular trafficking of many transmembrane receptors via
interactions with myosin VI.30
The presence of a GIPC homolog in M. brevicollis is consistent with the identification of adhesion GPCRs
in choanoflagellates.53,54 Overall, full length GIPC proteins from human and M. brevicollis (UniProt ID:
A9VCZ3_MONBE, termed mbGIPC) share 56% sequence identity over 79% of the protein. The human GIPC
protein is a Class I PDZ binding domain, as defined above. Recognition of the P-2 Ser/Thr residue is facilitated
by hydrogen bond formation with a conserved histidine in the first position of the conserved αB helix, termed
αB-1.26 The human and choanoflagellate GIPC PDZ domains are 58% identical over 88% of the PDZ sequence,
as defined by UniProt boundaries, including shared carboxylate-binding loop sequences of ALGL and
conservation of the Class I-defining histidine in the αB-1 position (Figure S1A).
We expressed and purified mbGIPC PDZ using previously described methods, and as described in more
detail in the Materials and Methods.38,55 Briefly, we used recombinant expression in Escherichia coli cells,
followed by affinity and size exclusion chromatography to produce purified mbGIPC PDZ protein. With protein
in hand, we crystallized and solved the structure of mbGIPC PDZ to a high resolution of 1.2 Å, as described in
the Materials and Methods and Supplementary Information. Overall, this structure is consistent with the conserved
PDZ fold, characterized by the central five-stranded antiparallel b-sheet (bA-E) (Figure 1). As mentioned above,
while many PDZ domains contain two a-helices (aA-B), it appears that aA is slightly strained and therefore not

fully formed in the mbGIPC structure, a characteristic
that is also true of the human GIPC PDZ domain (PDB
IDs: 5V6B and 5V6T).30 The peptide ligand forms an
additional strand of the central b-sheet (Figure 2A).
Data collection and refinement statistics are in Table
S1A.
Although we had added a peptide matching the
GAIP sequence, a high affinity human GIPC PDZ
target, during crystallization, we were surprised to see
that our crystal structure lacked the bound peptide.
Instead mbGIPC was interacting with the C-terminal
tail of a molecule related by symmetry (Figure S1B).
This is a common mode of co-crystallization for PDZ
domains and ligands, e.g., in the NHERF1 PDZ bound
to the cystic fibrosis transmembrane conductance
regulator (CFTR) structure, as well as others.29,56 The
NHERF1 PDZ1-CFTR example is distinct from our
structure, however, in that the C-terminus of mbGIPC
is not a Class I PDZ-satisfying motif (sequence:
KSFDEI). In our structure, which we will refer to as
Figure 2. The crystal structure of the mbGIPC PDZ domain. (A)
The interaction of mbGIPC (gray) with the C-terminal tail of a
mbGIPCSFDEI, we see that the P0 Ile is accommodated
molecule related by symmetry (green), backbone atoms shown in
by a hydrophobic pocket, as expected in Class I PDZ
stick, reveals a canonical PDZ-peptide interaction where the
peptide forms an additional strand of an antiparallel b-sheet.
interactions. However, the conserved αB-1 H157
Distances are labeled. (B) Average fluorescence polarization
residue is forming hydrogen bonds with the Asp in the
displacement isotherms are shown for mbGIPCtrunc PDZ.
P-2 position (distance: 2.6 Å), as well as the Ser in the
Titration curves correspond to the following peptides: GAIP
(circles), B1AR (squares), TYRP1 (diamonds), and a decameric
P-4 position (2.8 Å) (Figure S1C).
peptide matching the C-terminal residues of the construct, ending
In order to determine if this interaction is a
in “SFDEI” (triangles). Error bars indicate the standard deviation
crystal artifact, we created a truncated mutant,
from the mean for triplicate experiments. (C) Alignment of
mbGIPC PDZ domains with three separate C-terminal tail
mbGIPCtrunc, lacking the final 7 residues of our original
sequences (gray ribbon, RMSD = 0.21 Å for ~350 main chain
construct (or K181D), and calculated binding affinities
atoms), with tail sequences as sticks and colored as labeled. (D)
The conservation between mbGIPC (gray cartoon, with cyan side
for human GIPC targets using fluorescence
chain residues as sticks; peptide is in cyan ribbon) and human
polarization. We first measured the binding affinity of
GIPC (PDB ID: 5V6B, with Plexin-D1 C-terminal peptide from
mbGIPCtrunc for a decameric fluorescent reporter
5V6T (hot pink ribbon); gray cartoon with hot pink side chain
residues as sticks). Residues in the peptide-binding cleft are
peptide matching the sequence of GAIP (F*labeled. All stick representation is colored by heteroatom
QGPSQSSSEA, where F* = FITC or fluorescein
(O=red, N=blue).
isothiocyanate), calculating a KD = 0.29 ± 0.02 µM in a
quadruplicate experiment (Figure S1D). Next, we determined the affinities of a number of human GIPC PDZ
targets using competition experiments, including decameric peptides of the C-termini of GAIP (QGPSQSSSEA),
tyrosinase-related protein 1 (TYRP1, sequence: KLQNPNQSVV), and the b-1 adrenergic receptor (B1AR,
sequence: RPGFASESKV) (Table 1, Figure 2B). Experimental protocols were based on previously described
methods and are described in more detail in the Materials and Methods.38,55,57,58
The binding affinities of mbGIPCtrunc PDZ for human GIPC PDZ targets suggest a large degree of
conservation in selectivity determinants. Specifically, the affinity of mbGIPC PDZ for GAIP is 0.23 µM, despite
a BLASTP search revealing no obvious GAIP homolog in M. brevicollis.59 This result also suggests a minimal

effect of the fluorescein moiety in binding. The binding
affinities for TYRP1 and B1AR are ~10 and 20x worse,
respectively (Figure 2B). These values are still relatively
high to average affinity as compared to typical PDZ
domain interactions, which can range from the nanomolar
to hundreds of micromolar range, but are centered around
1-30 µM (11, 48, 50). Neither TYRP1 nor B1AR have
clear homologues in M. brevicollis, according to
BLASTP.59 Notably, a competition experiment with a decameric peptide matching the C-terminal sequence of
our original construct (“SFDEI” sequence: VEPKKSFDEI) revealed little to no binding, defined here as a Ki >
1000 µM (Table 1, Figure 2B). Thus, we concluded that the binding interaction in our original structure was a
crystal artifact. In order to investigate the stereochemistry of a peptide binding interaction with mbGIPC that is
not an artifact of crystallization, we mutated the final 5 residues of our original construct to those matching B1AR
(mbGIPCB1AR; C-terminal sequence: SESKV), GAIP (mbGIPCGAIP; SSSEA), and TYRP1 (mbGIPCTYRP1;
NQSVV) (Table S1A). Previous work from ourselves and others suggests that the P-5 position is an important
selectivity determinant in some PDZ domains.37,38 However, we chose to keep this residue a lysine in our new
constructs, due to crystal lattice contacts made by the lysine side chain, suggesting it may be important for
crystallization (Figure S1E).
All 3 complexes successfully crystallized in the same space group as mbGIPCSFDEI and we determined
crystal structures of mbGIPCB1AR and mbGIPCGAIP. The overall conformations of these structures to each other,
as well as to the mbGIPCSFDEI structure, were very similar, with pairwise structural alignment RMSD values £
0.21 Å for ~350 main chain atoms (Figure 2C). We were unable to fully refine the mbGIPCTYRP1 structure despite
a successful molecular replacement solution, due to anisotropic data and relatively low resolution, compared to
the others. Partial refinement (Rwork/Rfree = 24.3/28.9) shows clear peptide-specific density, confirming that this
sequence interacts with mbGIPC in a manner that is consistent with PDZ domain peptide binding (Figure S1F).
However, our structural analyses of the mbGIPC and human GIPC PDZ domains will be limited to the
mbGIPCB1AR and mbGIPCGAIP structures.
Our mbGIPC structures share high structural similarity with the human GIPC PDZ domain. Structural
alignment of main chain atoms between the mbGIPCB1AR and hGIPC PDZ domain (PDB ID: 5V6T) is 0.607 Å
over 299 main chain atoms. This human GIPC PDZ structure was crystallized with the intracellular region of
Plexin-D1 (C-terminal sequence: CYSEA) and the structures confirm that the peptide binding clefts of mbGIPC
and human GIPC are very well conserved, with only two conservative substitutions (using human GIPC
numbering): T148S and R159K (Figure 2D). We were unable to purify soluble human GIPC PDZ in our lab,
despite testing multiple constructs (including using a SUMO-tag), but our data strongly suggests that the binding
affinities would be similar between these domains.
Structure Characterization of mbSHANK1 PDZ
We previously compared binding affinities for another M. brevicollis PDZ domain, that of mbSHANK1
(UniProt ID: A9V7E4_MONBE), a protein that is homologous to human SHANK1 (Figure S2A).55 In this work,
we also created a homology model of mbSHANK1 PDZ using SwissModel and predicted stereochemical
differences in the peptide binding pockets between these two proteins, specifically in those residues that interact
with the P-3 position.55 Here, we expand that investigation by presenting the crystal structure of mbSHANK1 PDZ
(Figure 3A, Table S1B).

The protein mbSHANK1 PDZ was
expressed and purified as previously described.55
Crystallization of this protein in complex with a
fluoresceinated peptide matching the C-terminus of
GIRK3 (F*-GIRK3, sequence: F*-LPPPESESKV)
is described in the Materials and Methods and
Supporting Information. We collected data to a high
resolution of ~2.2 Å, however phasing by molecular
replacement and structure refinement proved
challenging. We employed an iterative Rosetta
modeling approach coupled with Phenix in order to
determine a molecular replacement solution with
high confidence, as described in detail in the
Supplementary Information.60–63 Our refinement
difficulties were due to a large degree of anisotropy
in the diffraction data. Specifically, the highresolution limit along the a* and b* directions (2.2
Å) was substantially higher than that along the c*
direction (3.4 Å). We were ultimately able to refine
this model by truncating and scaling the reflections
file appropriately, using the UCLA-DOE
Diffraction Anisotropy Server.64 Crystallization
attempts with a fluorescent b-PIX peptide
(sequence:
F*-NDPAWDETNL)
were
unsuccessful, despite binding mbSHANK1 PDZ
with much higher affinity (KD = 7.3 µM for

Figure 3. The crystal structure of the mbSHANK1 PDZ domain. (A)
The mbSHANK1structure (blue cartoon, peptide in stick
representation) is similar to a previously reported homology model
(gray cartoon), RMSD = 0.668 Å over 276 main chain atoms.55 The
black arrows highlight the differences in the flexible bB-bC loop. All
sticks are colored by heteroatom (O=red, N=blue) and the peptide
positions are labeled. (B-C) The interactions of the mbSHANK1
PDZ domain (gray cartoon, with side chains as sticks) with the F*GIRK3 peptide (blue sticks, interchangeably referred to as “GIRK3”
peptide, since the fluorescein moiety is unresolved in the crystal
structure) is characteristic of PDZ-peptide interactions.
Measurements between interacting residues in the peptide-binding
cleft are labeled. The GIRK3 peptide is labeled, and the sequence
included in the figures is in (B). There is an additional peptide residue
resolved in the crystal structure, the P-6 Pro, but it does not make
interactions with mbSHANK1 PDZ. (D) Phylogenetic tree showing
the relationship of a number of SHANK and SNX27 PDZ domain
sequences from 11 organisms. SNX27 sequences are colored red.
The mbSHANK1 and mbSNX27 sequences sit at the branch point of
the other SHANK and SNX27 sequences.

mbSHANK1 PDZ, and 5.1 µM for SHANK1 PDZ),
as previously reported (Table 2).55 For comparison,
previous attempts to get KD values of mbSHANK1
and human SHANK1 PDZ domains with the F*GIRK3 peptide were incomplete, with estimates of
affinities >1000 µM for each (data not shown). We
were also unable to grow crystals of mbSHANK1 in the apo form or following incubation with non-fluorescent
versions of either the b-PIX or GIRK3 peptides.
The crystal structure of mbSHANK1 bound to F*- GIRK3 is structurally very similar to our previously
determined homology model.55 The overall RMSD of these two structures is 0.668 Å over 276 main chain atoms,
with the largest discrepancy occurring in the flexible bB-bC loop (Figure 3A). In our structure, we see noncovalent interactions between T471 and the side chains of the P-4 Ser and P-5 Glu residues, as well as the P-5 Glu
carbonyl, which may have helped to stabilize the bB-bC loop for crystallization and may explain why this
complex crystallized despite a relatively low binding affinity, although six residues of the loop are disordered in
our structure (Figures 3B-C). In addition, we see electrostatic interactions between D488 and the P-1 Lys, as well
as H517 and R518 with the P-2 Ser (Figure 3C).
In our previous work and based on our mbSHANK1 homology model, we hypothesized that the modest
increase in affinity for b-PIX by mbSHANK1 PDZ (Ki = 13 µM versus 20 µM for human SHANK1 PDZ) was

due to an additional arginine residue that
was located near the P-3 position, and, we
figured, positioned to interact directly with
the P-3 Glu.55 Interestingly, our
experimental structure reveals that neither
of the arginine residues in the vicinity are
interacting with the P-3 Glu of GIRK3.
However, we do see that the sequence and
length of the bB-bC loop, which directly
interacts with the peptide P-4 Ser and P-5
Glu residues in our structure, varies quite
dramatically: the residues of the 11-residue loop for mbSHANK1 PDZ are not conserved at all with those of the
18-residue loop of human SHANK1 PDZ. It is unclear how these loops may differentially interact with the P-4
Asp and P-5 Trp of b-PIX, but otherwise, the crystal structure confirms that the peptide-binding clefts are generally
conserved.55
When we ran our initial BLASTP search for SHANK1 PDZ homologues in M. brevicollis, the top two
sequence hits were relatively close in sequence identity: A9V7E4_MONBE, with 34% sequence identity over 93
residues, as well as A9URU5_MONBE, with 36% sequence identity over 89 residues (domain boundaries for
human SHANK1 PDZ (residues 663-757) as defined by UniProt). Sequence alignments using the full-length
A9V7E4_MONBE protein and the human proteome confirmed its homology to the SHANK protein family,
specifically due to the additional presence of ankyrin repeat domains, as well as SH3 and SAM domains.45,65
Sequence alignments using the full-length A9URU5_MONBE sequence and human proteome suggested that it is
a homologue of sorting nexin-27 (SNX27), with 25% sequence identity over 96% of the protein. Therefore, we
will refer to A9URU5_MONBE as mbSNX27.
We were interested in the relationship between the PDZ domain sequences in these four proteins due to
the similar sequence similarities between mbSHANK1 and mbSNX27 PDZ domains and human SHANK1 PDZ.
Therefore, we conducted a phylogenetic tree analysis of 10 PDZ sequences for SHANK1 or SNX27 homologues
in a variety of organisms, as well as the PDZ domain sequences of mbSHANK1 and mbSNX27 (Figure 3D).
Because we see that mbSHANK1 and mbSNX27 sit at the branch point between the SNX27 and SHANK1
sequences, we expressed and purified SNX27 and mbSNX27 PDZ domains, as described in the Materials and
Methods, and compared binding affinities for all four domains using fluorescence polarization to 6 decameric
peptides matching the C-termini of: b-PIX, GIRK3, and mGluR1, as well as A9UP44_MONBE,
A9UXE1_MONBE, and A9V724_MONBE, which were previously identified as potential M. brevicollis targets
of mbSHANK1 (Figures S2B-D, Table 2).55
Our results reveal that overall, peptides which bind human SNX27 PDZ with relatively high affinity also
bind mbSNX27 PDZ very strongly (Table 2). As previously reported, this is also true with human SHANK1 and
mbSHANK1 PDZ domains (Table 2).55 However, in all cases, the exact order of highest to lowest affinity
peptides is distinct, perhaps reflective of single substitutions in the peptide binding cleft. We described the
differences for SHANK1 and mbSHANK1 PDZ domains above and previously.55 A homology model of
mbSNX27 PDZ, using SNX27 PDZ as a template (PDB ID: 6SAK) contains the following substitutions at
residues that may interact with the peptide (numbering based on SNX27): R58K, V61T, A83H, and R122I
(Figure S2E). In addition, while the mGluR1 peptide binds the human PDZ domains with moderate affinity, it
shows no measurable affinity for either of the M. brevicollis PDZ domains. Taken together, the resulting binding
affinities are consistent with our central hypothesis that the target selectivity of PDZ lineages were set early in
Table 2. Binding affinities of SHANK1, SNX27, mbSHANK1 and
mbSNX27 PDZ domains.
SHANK1 and mbSHANK1 PDZ domain measurements are previously
published, with the exception of the GIRK3 peptide.55

evolution, even in proteins that appear to be closely related to each other, e.g., SHANK1 and SNX27 PDZ
domains, based on overall sequence identity.
Concluding Remarks
Structural comparison of the peptide-binding clefts and peptide interactions of homologous domains from
organisms related by hundreds of millions of years of evolution has the potential to provide insight into signaling
networks in those species. Here, we chose to use structural biology and biochemistry to investigate two PDZ
domain-containing proteins that are important in human neuronal signaling in a species of choanoflagellates, our
closest non-metazoan ancestors. Many of the human targets of SHANK1 and GIPC1 are either not conserved in
choanoflagellates or do not contain PDZ binding sequences.55 However, we find that the peptide binding-cleft
residues and binding affinities for human and/or choanoflagellate peptides are generally conserved in these related
domains. Specifically, we see strong binding affinity correlations in SHANK1 and mbSHANK1 versus SNX27
and mbSNX27 PDZ domains, despite binding cleft substitutions in both cases.
Our structures of two unique M. brevicollis PDZ domains provide the first structural determination of
choanoflagellate PDZ domains to our knowledge. Furthermore, our comparisons with known human PDZ domain
structures, as well as homology and Rosetta modeling confirm that because the PDZ domain fold is so well
conserved, it is possible to get an initial idea of a PDZ domain structure without experimental structure
determination. We hypothesize that these types of analyses can be applied to PDZ domains from multiple
organisms related by evolution.
Protein-protein interactions that involve PDZ domains act as critical nodes for signaling and trafficking
pathways in a cell. It is clear that this is true in differentiated cells, such as those in complex multicellular
organisms, as well as in single-celled organisms. Deciphering the PDZ-mediated interactions in choanoflagellates
may elucidate important characteristics of the selectivity determinants and the evolution of this important peptidebinding domain. Furthermore, there are a number of proteins and protein architectures that contain PDZ domains
in choanoflagellates that are not conserved in humans. Future work could investigate how these proteins, for
example A9VDV9 mentioned above, act in signaling pathways in M. brevicollis and how this provides insight
into the transition from uni- to multicellular life on Earth. Taken together, we suggest that investigating the
structure-function relationship for individual domains in both uni- and multicellular organisms is an important
component in building a holistic understanding of the signaling networks of an organism and in understanding
the origin of multicellularity.
Materials and Methods
Protein Expression and Purification. Expression and purification of all human and M. brevicollis PDZ domains
followed a similar protocol as previously reported for mbSHANK1 PDZ.55 Histagged versions of the PDZ
domains were inserted into the pET28a+ vector (GenScript) and expressed in Escherichia coli BL21 (DE3) cells.
Cells were lysed using sonication and immobilized metal-affinity chromatography (5 mL HisTrap (GE
Healthcare)) was used to purify proteins from the clarified supernatant. The wash buffer used was: 25 mM
imidazole pH 8.5, 25 mM Tris pH 8.5, 25 mM NaCl, 10% (v/v) glycerol, and 0.25 mM TCEP, and elution buffer
was: 400 mM imidazole pH 8.5, 25 mM Tris pH 8.5, 50 mM NaCl, 10% (v/v) glycerol, and 0.5 mM TCEP. With
the exception of human SHANK1 and SNX27 and mbSNX27 PDZ domains, the protein was then dialyzed in
dialysis buffer (same as gel filtration buffer described below), and incubated with PreScission protease to cleave
off the His-tag. The cleaved protein was then purified using a second nickel column with the wash and elution
buffers described above. All proteins were further purified on a Superdex S75 column, using gel filtration buffer
[25 mM Tris pH 8.5, 125 mM NaCl, 10% (w/v) glycerol, 0.5 mM TCEP]. Proteins were concentrated using

Amicon centrifugal concentrators (3 MWCO). Concentrated proteins used in fluorescence polarization assays
were flash frozen in liquid nitrogen for storage at -80°C. Proteins used for crystallization were stored at 4°C.
Proteins were quantitated with the A280 and the experimental extinction coefficient values of: 1490 cm1
*M-1 for all mbGIPC PDZ domains (including mbGIPCSFDEI, mbGIPCtrunc, mbGIPCB1AR, mbGIPCGAIP, and
mbGIPCTYRP1), 8480 cm-1*M-1 for SHANK1 PDZ, 11000 cm-1*M-1 for mbSHANK1, 9970 cm-1*M-1 for
mbSNX27 PDZ and 2980 cm-1*M-1 for SNX27 PDZ.
Crystallization, Data Collection, and Structure Determination. Prior to crystallization, all PDZ domains were
dialyzed into a crystallization buffer [25 mM NaCl, 10 mM Hepes pH 7.4] for 2-4 hours. The protein
concentrations used for crystallization were as follows: mbSHANK1 (6 mg/mL), mbGIPCSFDEI (23.4 mg/mL),
mbGIPCB1AR (17 mg/mL), mbGIPCGAIP (22.8 mg/mL), and mbGIPCTYRP1 (27.3 mg/mL). Peptide was added at a
final concentration of 1 mM and incubated with protein for 1-hour prior to crystallization for F*GIRK3:mbSHANK1 PDZ. All initial crystallization conditions were identified using the PEG/Ion screen
(Hampton Research). The crystallization conditions of crystals used for data collection were: mbGIPCSFDEI [100
mM ammonium tartrate dibasic pH 7.0, 12% (w/v) PEG 3350], mbGIPCB1AR [200 mM sodium malonate pH 7.0,
20% (w/v) PEG 3350], mbGIPCGAIP [4% (v/v) Tacsimate pH 4.0, 12% (w/v) PEG 3350], mbGIPCTYRP1 [100 mM
DL-Malic acid pH 7.0, 12% (w/v) PEG 3350], and mbSHANK1 [250 mM NaCl, 100 mM Bis-Tris pH 5.5, 32%
(w/v) PEG 3350].
For data collection, crystals were transferred into cryoprotectant buffer. For mbSHANK1, this was well
solution plus 20% (w/v) glycerol. For other proteins, 15% (w/v) glycerol was added directly to the respective
PEG/Ion screen solution. The crystals were flash-cooled by plunging into liquid nitrogen. Data was collected at
the Advanced Light Source (ALS) at the Lawrence Berkeley National Laboratory (LBNL) on beamline 5.0.1, at
l=0.977410 Å over 360°, with Df=0.25° frames and an exposure time of 0.5 s per frame. Data were processed
using the XDS package (Table S1).83–85 Molecular replacement was performed using Phenix with the following
search models: mbGIPC (PDB ID: 5V6B, human GIPC) and mbSHANK1 (de novo structural model using the
Robetta server and Rosetta optimization as described in the Supplemental Information).60,86,87 Refinement was
performed using Phenix, manual refinement was done using Coot, and model geometry was assessed using
Molprobity and the PDB validation server.60,86,89–93 All crystal data and refinement statistics are in Table S1.
Additional details regarding the structure determination of mbSHANK1 is in the Supplemental Information. PDB
accession codes for the structures presented here are: 6X1X (mbGIPCSFDEI), 6X20 (mbGIPCB1AR), 6X22
(mbGIPCGAIP) and 6X23 (mbSHANK).
Binding assays by fluorescence polarization. Fluorescence polarization assays were performed as previously
described.25,38,55,58 Replicate experiments were performed to determine the KD values of mbGIPCtrunc PDZ (N=4)
for the fluorescence peptide, F*-GAIP (FITC-QGPSQSSSEA), and SNX27 PDZ (N=3) for the fluorescent
peptides, F*-b-PIX (FITC-NDPAWDETNL) and F*-GIRK3 (FITC-LPPPESESKV) (Figures S1D, S2B). For
mbGIPCtrunc PDZ we determined a KD value of 0.29 ± 0.02 µM for F*-GAIP. For SNX27 we determined a KD
value of 0.022 ± 0.007 µM for F*-b-PIX and 0.327 ± 0.135 µM for F*-GIRK3. Limited yield of purified
mbSNX27 resulted in the inability to calculate KD values for that protein, thus, we reported IC50 values for our
unlabeled peptides (Figure S2D, Table 2).
Competition experiments: The final protein concentrations for Ki experiments were equal to: 0.6 µM for
mbGIPC PDZ, 0.05 µM for SNX27 PDZ, and 5 µM for mbSNX27 PDZ. For SHANK1 and mbSHANK1 PDZ
Ki experiments with the GIRK3 peptide, we used 10 µM protein (based on previously-determined KD values of

7.3 µM for mbSHANK1 PDZ, and 5.1 µM for SHANK1 PDZ).55 Competition experiments were performed in
triplicate, using the following reporter peptides at 30 nM final concentration: mbGIPC (F*-GAIP), SNX27 (F*b-PIX) and mbSNX27 (F*-b-PIX). Binding affinities for Ki experiments were determined using SOLVER and
IC50 values using Kaleidagraph, as previously described (Figures 2B, S2C-D).38,57,58
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Supplemental Tables and Figures:

Figure S1. Crystal contacts in mbGIPCSFDEI structure and electron density for peptide in mbGIPCTYRP1. (A)
Sequence alignment of human GIPC and mbGIPC PDZ domains. (B) The spatial relationship between mbGIPC (green
cartoon) PDZ and a molecule related by symmetry (gray cartoon, mbGIPC’) is shown. The last 5 residues of the
mbGIPC’ C-terminal tail (sequence SFDEI) are shown in gray stick. (C) The binding of mbGIPC (green cartoon, H157
side chain in stick representation) to the C-terminal tail of mbGIPC’ (gray sticks and labeled) is unconventional and a
crystal artifact. (D) The average fluorescence polarization isotherm is shown for mbGIPCtrunc PDZ and the F*-GAIP
peptide (at 30 nM), including the standard deviation for each data point. This experiment was performed in quadruplicate
and the calculated KD = 0.29 ± 0.02 μM. (E) The K182 residue in mbGIPCSFDEI PDZ (green sticks) makes crystal
lattice contacts with the main chain carbonyl atoms of R134 and V135 in a molecule related by symmetry, mbGIPC’
(gray sticks). For this reason, we chose to keep a lysine in this position in our other mbGIPC constructs (mbGIPCB1AR,
mbGIPCGAIP, and mbGIPCTYRP1). (F) Final refinement of mbGIPCTYRP1 proved challenging, so we did not deposit
this structure in the Protein Data Bank. However, there is clear electron density for the C-terminal sequence, NQSVV
(2Fo-FC map in blue mesh and contoured at 1s), and it is consistent with mbGIPC binding to the other C-terminal
sequences (GAIP and B1AR). Here, mbGIPC is in gray cartoon with side chain sticks in gray. The TYRP1 sequence is
in green stick representation and labeled. For all, sticks are colored by heteroatom (O=red, N=blue).

Figure S2. Structural and biochemical characterization of mbSNX27. (A) Sequence alignment of human SHANK1 and mbSHANK1
PDZ domains. Secondary structure elements are labeled by arrows (b-strands) and wavy lines (a-helices). (B) Example fluorescence
polarization isotherms are shown for SNX27 PDZ and the F*-b-PIX (black squares) and F*-GIRK3 peptides (black circles, both
reporter peptides at 30 nM). (C-D) Average fluorescence polarization displacement isotherms are shown for SNX27 PDZ (C) and
mbSNX27 PDZ (D). Titration curves are shown for the following peptides: b-PIX (circles), GIRK3 (squares), and mGluR1
(diamonds), or choanoflagellate proteins A9UP44 (triangles), A9UXE1 (upside-down triangles), and A9V7Z4 (gray circles). Error
bars indicate standard deviation from the mean for triplicate experiments. The reporter peptide used in both experiments was F*-bPIX. (E) The conservation between mbSNX27 (gold cartoon, with side chain residues as sticks) and human SNX27 (PDB ID: 6SAK,
gray cartoon with side chain residues as sticks) is shown. The peptide (GIRK3 sequence: ESESKV) is from an additional human
SNX27 structure (3QE1) and is shown as gray ribbon and labeled. The RMSD value between the human SNX27 structures is 0.377
Å over 302 main chain atoms. The mbSNX27 PDZ structure was made using SwissModel with 6SAK as a template. Residues in the
peptide-binding cleft are labeled. All stick representation is colored by heteroatom (O=red, N=blue).

Part 2: Structural and binding studies of Class A sortase of Streptococcus agalaticae
Abstract (adapted from Piper et al. In review. JBC.)
Gram-positive bacteria contain sortase enzymes on their cell surfaces that catalyze transpeptidation
reactions critical for proper cellular function. In vitro, sortases are used in sortase-mediated ligation (SML)
reactions for a variety of protein engineering applications. Historically, sortase A from Staphylococcus aureus
(saSrtA) has been the enzyme of choice for SML reactions. However, the stringent specificity of saSrtA for the
sequence motif LPXTG limits its uses. Here we investigate the contribution of this b7- b8 loop, located between
the catalytic cysteine and arginine residues and immediately adjacent to the target binding cleft, by designing and
testing chimeric sortase enzymes. Our chimeras utilize natural sequence variation of Class A sortases from four
species engineered into the SrtA sequence from Streptococcus agalaticae (sagSrtA). We crystallize and solve the
first known full-length structure of sagSrtA and are working on solving a sagSrtA chimera and peptide-bound
structures. These studies provide the foundation for a deeper understanding of sortase target selectivity and can
expand the sortase toolbox for future SML applications.
Introduction (adapted from Piper et al. In review. JBC.)
Sortases are cysteine transpeptidase enzymes
that gram-positive bacteria use to covalently attach
proteins to their cell wall for various functions,
including to assemble pili or display virulence
factors.1–3 There are 6 recognized classes of sortase
enzymes (classes A-F), with in vivo roles ranging
from general purpose or “housekeeping” functions
(classes A and E), to more specific roles such as the
construction of the bacterial pilus (Class C).1,4 These
enzymes recognize a cell wall sorting signal (CWSS)
on the outer membrane of gram-positive bacteria.1,5
For Class A sortases, the CWSS is the sequence
LPXTG.1,5 Using previously published numbering
(L=P4, P=P3, X=P2, T=P1, and G=P1’), P4, P3
and/or P1’ of this motif vary amongst different
classes.5 Following target recognition, a His-CysArg catalytic triad facilitates a transpeptidation
reaction whereby the CWSS is first cleaved between
the P1 and P1’ residues via nucleophilic attack by the
catalytic Cys, resulting in a thioester linkage with the
P1 position of the CWSS. Resolution of this acylenzyme intermediate is then achieved by
nucleophilic attack by an amino group displayed on
the cell wall building block lipid II, or in the case of
pilus formation, displayed on a separate protein
subunit.1,3,5,6 The final result is formation of a new
amide linkage, with the portion of the substrate Nterminal to the CWSS now covalently attached at its
C-terminus to the amine nucleophile ligation partner.
The ability to cleave a substrate sequence and
subsequently ligate a second component (for
example a protein or synthetic peptide derivative)
make sortases an attractive tool for protein

Figure 1. The sortase-fold is conserved in all classes of bacterial
sortases. (A) The peptide-bound structure of S. aureus SrtA
(saSrtA) is shown in cartoon representation, with b-strands colored
and labeled (PDB ID: 2KID) 17. The side chains of the catalytic
residues (H120, C184, and R197) are shown as sticks, colored by
heteroatom (O=red, N=blue, S=yellow), and labeled. The disulfide
-linked peptide analog, Cbz-LPAT*, where Cbz is a
carbobenzyloxy protecting group and T* is (2R,3S)-3-amino-4mercapto-2-butanol, is shown as black sticks and colored by
heteroatom 17. A zoomed-in version of the active site is shown in
the black box, with features indicated as in (A). The variable loops
are labeled and indicated by gray arrows. (B) The overall sortasefold is well conserved in proteins of different classes. Here,
structures for Class B (PDB ID 1NG5), Class C (3O0P), Class D
(2LN7), Class E (5CUW), and Class F (5UUS) sortases are in
cartoon, with conserved b-strands colored as in (A), highlighting
the 8-stranded sortase-fold. The conserved catalytic triad is shown
in sticks (and colored by heteroatom) for all.

engineering efforts, commonly called sortase-mediated ligation (SML) or sortagging.3 Sortase A from
Staphylococcus aureus (saSrtA) was the first of these enzymes discovered and continues to see widespread use
for in vitro SML experiments.1,7 Recent years have seen notable improvements in SML technology, including
strategies for limiting the reversibility of the ligation reaction, and the development of saSrtA variants with
dramatically improved catalytic efficiency.3,8,9 However, as a consequence of the narrow substrate selectivity of
saSrtA10, the majority of SML examples rely on the combination of one ligation partner displaying an LPXTG
motif near its C-terminus with another possessing one or more N-terminal glycines. This restricted substrate scope
can be advantageous, for example in the use of SML for labeling specific polypeptides in complex mixtures, but
it also represents a limitation for certain applications (PMID: 33290621).11,12 Highlighting this point, an
increasing number of studies have demonstrated that the use of naturally occurring sortases or engineered sortases
with altered substrate selectivity offer distinct advantages such as reducing the necessity for point mutations in
protein semisynthesis applications12, enabling the labeling of endogenous proteins that do not naturally contain
the LPXTG motif11,13, and allowing labeling of multiple sites within the same protein target.11,14 Thus, the
engineering and discovery of sortases with altered substrate profiles, along with a better understanding of the
biochemical basis for sortase substrate selectivity, represent important areas for the continued development of
SML technology.
With respect to substrate recognition, previous mutagenesis and structural studies of various sortases
provide a wealth of knowledge about initial ligand recognition and subsequent cleavage (thioesterification), as
well as nucleophile recognition and mechanistic details of peptide ligation (transpeptidation).1,2,10 Specifically,
the catalytic residues of all native sortases identified to date are (using saSrtA numbering unless specified
otherwise): His120 (general acid/base), Cys184 (nucleophile, acyl-enzyme intermediate), and Arg197 (transition
state stabilization) (Figure 1A).1,10 Additionally, directed evolution studies have identified mutations
(P94R/D160N/D165A/K190E/K196T) that are together able to boost the catalytic efficiency of saSrtA by 120fold.8 Of these 5 mutations, several are located in two of the three structurally conserved loops in Class A sortases
located near the peptide-binding cleft: those between the b4, b5 strands (b4-b5 loop), the b6, b7 strands (b6-b7
loop, where D165A occurs), and the b7, b8 strands (b7-b8 loop, where K190E and K196T are located). Notably,
while the increase in enzyme activity afforded by these mutations included a 3.6-fold increase in kcat, the effect
was dominated by a 33-fold decrease in KM, suggesting these loop residues may be important in CWSS
recognition.8
Additional evidence for the role of loop residues has been obtained from more targeted directed evolution
and mutagenesis studies. For example, it has been demonstrated that the b6-b7 loop of saSrtA directly confers
specificity at P4 of the recognition motif (LPXTG), and residues other than leucine (L) can be accommodated
using sortases with mutations in the b6-b7 loop.11,12,15 Indeed, substitution of the b6-b7 loop residues from saSrtB
into the saSrtA enzyme alters substrate recognition to that of a sortase B protein (NPQTN).16 Turning to the b7b8 loop, the NMR structure of saSrtA covalently bound to a modified LPAT* peptide mimetic revealed a
non-covalent interaction between W194 in saSrtA and the Thr residue in P1 (LPXTG).17,18 Mutation of W194 in
saSrtA decreased the reaction rate, although it was not essential to catalysis.18 Taken together, these past studies
reveal that sequence variation within sortase loops directly affects both activity and selectivity for target ligands.
Furthermore, conservation of the closed eight-stranded b-barrel core in all sortase A-F structures that have been
reported to date suggests that these principles may apply to non-Class A sortases as well (Figure 1B).2
The published structure of S. pneumoniae SrtA (spSrtA,
PDB ID: 4O8L) is of a domain swap dimer. In its dimer form,
spSrtA is inactive thus its structure does not give insight to the
active conformation of Class A sortases. Looking in the Protein
Database, we found Streptococcus agalaticae (sagSrtA, PDB
ID: 3RCC) crystallized as a dodecamer with six monomeric
units forming a ring and two rings stacked together. With the
knowledge that sagSrtA has previously been crystallized, it
forms the basis for our structural investigation of chimeric
sagSrtA variants and co-crystallization structures of the Figure 2. b7-b8 loop sequences of chimeric
variants.
LPATXG substrate with sagSrtA.

Results
Loop-swapped b7-b8 chimeric enzymes selectivity for P1’
Previous research in the lab has shown that the
broaden substrate scope can be attributed to the role A
B
that b7-b8 loop playing a key role in the differing
substrate preferences.19 Moreover, variations in
b7-b8 loop sequences can substantially impact
overall enzyme activity, affording chimeric sortases
that outperform their wild-type counterpart in vitro.19
Using the full-length sequence of SrtA in
Streptococcus agalaticae as the base, four chimeric
enzymes were created using previous tested b7-b8
loops to confirm trends seen before. These chimeras
include b7-b8 loop residues from Staphylococcus
aureus (sagSrtAaureus), Enterococcus faecalis
(sagSrtAfaecalis),
Listeria
monocytogenes
(sagSrtAmonocytogenes), and Streptococcus pneumoniae
Figure 3. (A) Substrate selectivity profiles for saSrtA and spSrtA.
(sagSrtApneumoniae) (Figure 2). Enzymatic assays were (B) Substrate selectivity profiles for wild-type sagSrtA and
preformed using LPATGG, LPATAG, and LPATSG chimeric sagSrtA variants. Substrate cleavage monitored via an
substrates to obtain the relative activity.
increase in fluorescence at 420 nm from reactions of fluorophorequencher probes with the generic structure Abz-LPATXG-K(Dnp)
(LPATX) in the presence of hydroxylamine. Bar graphs represent
mean normalized fluorescence (± standard deviation) from at least
three independent experiments.

Within the 2 hr time frame of our assay, wildtype sagSrtA is more promiscuous then saSrtA, able
to react with all three substrates. This promiscuity is
similar to spSrtA with a key difference in that sagSrtA cleaves LPATAG two-times more efficiently. When the
S. aureus b7-b8 loop is swapped in, we see that sagSrtAaureus mimics saSrtA’s selectivity for the glycine in the
P1’ position with an efficiency that is one-fifth of saSrtA. sagSrtAfaecalis has
Table 1. Substrate selectivity
an increase in efficiency with all three substrates, predominantly in the A- and
profiles for saSrtA, sagSrtA,
sagSrtAtrunc and spySrtA.
G-containing peptides. The sagSrtAmonocytogenes fundamentally mimics saSrtA
being selective only for the G-containing peptide but is seen to have even less
efficiency than sagSrtAaureus. Finally, sagSrtApneumoniae shows similar
efficiency and promiscuity to spSrtA for all peptides except for the Scontaining, being only half as efficient (Figure 3). All chimeric enzymes
followed promiscuity and selectivity trends seen when similar chimeric
enzymes were created using the Streptococcus pneumonia SrtA as the base
structure.19
Full-Length Structure of Streptococcus agalaticae SrtA
The published structure of sagSrtA is of a truncated version of the
enzyme, which removes the last nine residues from the C-terminus tail.20
The effects on activity due to this truncation was investigated via
fluorescence assays and revealed that sagSrtAtrunc is inactive for all three
substrates (Table 1). C-terminal tail is important in the enzymes structure
and its ability to cleave and ligate. To investigate this difference, we
expressed, purified, crystallized and solved the structure of full length
sagSrtA to a high resolution of 1.4 Å. Structural alignment of sagSrtAtrunc
(PDB ID: 3RCC) to full-length sagSrtA showed significant deviations
between the structures with an RMSD of 0.857 Å over 711 main chain
atoms. The b6-b7 and b7-b8 loops, both important in substrate recognition

Figure 4. Structural alignment of
sagSrtAtrunc (pink) and full-length
sagSrtA (aqua).

and cleavage, showed the greatest amounts of movement compared to other regions (Figure 4). This difference
in structure we hypothesize is due to the non-endogenous dodecameric interactions that the sagSrtAtrunc enzyme
was crystallized in causing shifts in structure to pack into the oligomeric form.
Streptococcus agalaticae swap aureus SrtA Structure

Figure 5. Structural alignment of
sagSrtA (aqua) and sagSrtAaureus
(purple). RMSD of 0.485 Å over 867
main chain atoms.

Upon obtaining the full length sagSrtA structure, we went on to
crystallize the chimeric loop swaps that we had created for enzymatic assays.
We were only able to crystallize the sagSrtAaureus even though the other loops
are of more similar lengths than the S. aureus b7-b8 loop. While solving the
structure we realized that the loop sequences was actually incorrect as the
asparagine was omitted (Figure 2, 5). This enzyme was also used in the
enzymatic assays and will need to be redone with the correct loop sequence.
This mistake did tell us that by removing the asparagine from the loop, it
does not affect the selectivity of sagSrtA. It still followed the same trend that
we expected.

Co-Crystallization
With a full-length structure obtained, we went on
to co-crystallize sagSrtA with our three substrates. To do
so, the enzyme is first inactivated by mutating the
catalytic cystine in position 206 to an alanine via sitedirected mutagenesis. With the correct plasmid in hand,
the inactive enzyme was expressed, purified and
crystalized. G-, S- and A-containing peptides were added
to a final concentration of 1 mM and incubated for an hour
at room temperature prior to crystallization. The
LPATGG peptide contains a fluorescein fluorophore Figure 6. (A) Structural alignment of sagSrtA and spySrtA.
producing yellow crystals that confirmed peptide and (B) Zoomed in b7-b8 loop.
protein interaction. Crystals looped from these cocrystallization setups have been sent to the ALS for data collection and currently structures are being solved.
Preliminary strucutral analysis using Streptococcus pyogenes SrtA (spySrtA) bound to LPATAG shows a
high structural alignment with an RMSD of 0.492 Å over 855 main chain atoms. Looking specifically at the loops
involved in substrate recogntion and selectivity, we see minimal movement in the b6-b7 and b7-b8 loops with
the greatest deviations between the structures in the b4-b5 loop. Enzymatic assays of spySrtA indicate a threefold increase in activity for glycine and serine in the P1’ position while a 2-fold increase for the alanine compared
to sagSrtA (Table 1). Examining the b7-b8 loop sequence, there is only a one residue difference between the
two. The third residue following the catalytic cystine in sagSrtA is a proline while in spySrtA is an isoleucine
(Figure 6). The rigidity of proline effects the flexibility of the loop thus causing the decrease in activity seen in
sagSrtA.
Looking more closely at LPATAG’s interaction with sagSrtA, the leucine in position P4 fits nicely into a
hydrophobic pocket. This pocket most likely would not be able to accommodate large hydrophobic residues due
to the size of the cavity (Figure 7A). The P1’ position of the peptide falls in a hydrophobic ridge which is also
restrictive of large hydrophobic residues (Figure 7B). The S-containing peptide is accommodated in this ridge as
the hydroxyl group is able to point out of the pocket. Finally, there are multiple hydrogen bonds made between

sagSrtA and positions P1, P2 and P3 of the peptide,
specifically with the catalytic arginine and the backbone of
the peptide (Figure 7C).
Conclusion
Target sequence recognition for Class A sortases is
not all rigidly selective like S. aureus SrtA for a P1’ glycine
but it seen to be able to accommodate many residues.14,21–23
Building off previous work in the lab, we look to understand
the fundamentals of sortase substate recognition through
structural analysis. S. agalaticae SrtA as the launching off
point of these studies due to a published structure. From our
studies, we also solved the first full-length structure of
sagSrtA and discovered that the published structure was a
crystal artifact. We also solved the structure of a chimeric
variant, sagSrtAaureus, but due to a wrong loop sequence, our
finding cannot be confirmed just yet but the asparagine that
was omitted does not seem to be a key residue in substrate
recognition. sagSrtA aligned to a high degree to spySrtA
allowing for preliminary structural analysis of peptide bound
Figure 7. Electrostatic surface of sagSrtA with
structure. Similar to spySrtA, sagSrtA also exhibited: (1) a LPATAG. (A) Hydrophobic pocket where leucine sits.
hydrophobic pocket that accommodates the P4 position, (2) (B) Hydrophobic ridge that restricts large hydrophobic
multiple hydrogen bond interactions and (3) a hydrophobic residues. (C) Hydrogen bonding of sagSrtA with
ridge limiting the residues compatible in the P1’ position. We peptide backbone and side chain.
also found that the proline within the b7-b8 loop sequence
of sagSrtA greatly hindered its ability to efficiently cleave its substrate. This work also has implications for the
further development of sortase-mediated ligation (SML) as a protein engineering tool.3,24
The development of these new sortase/substrate pairs has exciting consequences for SML engineering
efforts: (1) it increases options for dual-labeling single proteins or multiplexed labeling of multiple proteins in the
same systems25–27, and (2) it may reduce the need to mutate naturally occurring protein sequences in order to
render their termini compatible with SML. Developing a deeper understanding of how residues in these loops
affect substrate selectivity in all sortase classes may enable dramatic expansion of the sortase “toolbox”,
potentially allowing the development of ligases that are tailored to the needs of specific protein targets while also
limiting off-target effects.
Experimental Procedures (adapted from Gao et al. and Piper et al.)
Protein expression and purification. Wild-type spSrtA and saSrtA proteins were expressed and purified as
previously described.28 All other constructs, including chimeric and mutant proteins, were purchased from
Genscript in the pET28a(+) vector. In general, protein expression and purification protocols were very similar to
those previously described.28 Briefly, plasmids were transformed into Escherichia coli BL21 (DE3) competent
cells and grown in LB media, with protein induction at OD600 0.6-0.8 using 0.15 M IPTG for 18-20 h at 18°C.
Following cell harvest in lysis buffer [0.05 M Tris pH 7.5, 0.15 M NaCl, 0.0005 M
ethylenediaminetetraacetic acid (EDTA)], the protein was purified using a 5 mL HisTrap HP column (GE Life
Sciences, now Cytiva), using wash [0.05 M Tris pH 7.5, 0.15 M NaCl, 0.02 M Imidazole pH 7.5, 0.001 M TCEP]
and elution [wash buffer, with 0.3 M Imidazole pH 7.5] buffers. Size exclusion chromatography (SEC) was
conducted using a HiLoad 16/600 Superdex 200 column (GE Life Sciences, now Cytiva) in SEC running buffer
[0.5 M Tris pH 7.5, 0.15 M NaCl, 0.001 M TCEP]. Purified protein corresponding to the monomeric peak was
concentrated using an Amicon Ultra-15 Centrifugal Filter Unit (10,000 NWML) and analyzed by SDS-PAGE.
Protein not immediately used was flash frozen in SEC running buffer and stored at -80°C.

Peptide synthesis. Detailed synthetic procedures are provided in the Supplemental Data. Briefly, all peptides were
synthesized via manual Fmoc solid phase peptide synthesis (SPPS). Peptides were synthesized either individually
or in tandem using Fmoc Rink amide MBHA resin or Synphase lantern solid supports. All other materials,
including suitably protected Fmoc amino acids, and reagents for coupling, deprotection, and resin cleavage were
obtained from commercial sources and used without further purification. All peptides were purified using RPHPLC and their identities were confirmed via ESI-MS. Prior to use in sortase-catalyzed transacylation reactions,
each purified peptide was prepared as a concentrated stock solution in DMSO and/or H2O.
Fluorescence Assay for Sortase Activity. Reactions were performed in a Costar round-bottom, black 96-well plate
at a 100 µL reaction volume under the following conditions: 5 µM sortase, 50 µM peptide substrate, and 5 mM
hydroxylamine nucleophile. All reactions contained 10% (v/v) 10x sortase reaction buffer (500 mM Tris pH 7.5,
1500 mM NaCl, and 100 mM CaCl2). Reactions also contained residual DMSO from the peptide stock solutions
(0.5-1.5% (v/v), with the exception of the Phe- and Val-containing peptides at 5%). The peptides containing
phenylalanine or valine required 5% (v/v) DMSO for solubility under the reaction conditions. 1 mM TCEP was
also included in reactions utilizing the Abz-LPATCG-K(Dnp) substrate. Reactions were initiated by the addition
of the sortase enzyme, which were prepared as 10x stock solutions in 50 mM Tris pH 7.5, 150 mM NaCl, and 1
mM TCEP. Microplates were analyzed using a Biotek Synergy H1 plate reader. The fluorescence intensity of
each well was measured at 2-min time intervals over a 2-hr period at room temperature (lex = 320 nm, lem = 420
nm, and detector gain = 75). All reactions were performed in triplicate. For each substrate sequence, the
background fluorescence of the intact peptide in the absence of enzyme was subtracted from the observed
experimental data. Background-corrected fluorescence data was then normalized to the fluorescence intensity of
a benchmark reaction between wild-type saSrtA and Abz-LPATGG-K(Dnp).
Crystallization, Data Collection, and Structure Determination. The protein concentrations used for crystallization
was approximately 15 mg/ml. Peptide was added at a final concentration of 1 mM and incubated with protein for
1-hour prior to crystallization. All initial crystallization conditions were identified using the PEGRx screen
(Hampton Research). The crystallization conditions of crystals used for data collection were: sagSrtA [100 mM
MES monohydrate pH 6.0, 20% (v/v) 2-propanol, 20% (w/v) PEG monomethyl ether 2000] and
sagSrtA:LPATGG [80-120 mM sodium acetate trihydrate, 26-32% (w/v) PEG 1500].
For data collection, all co-crystallization crystals grown from lab made well solutions were transferred
into cryoprotectant buffer made of well solution plus 20% (w/v) glycerol. For full-length sagSrtA, 15% (w/v)
glycerol was added directly to the respective PEGRx screen solution. The crystals were flash-cooled by plunging
into liquid nitrogen. Data was collected at the Advanced Light Source (ALS) at the Lawrence Berkeley National
Laboratory (LBNL) on beamline 5.0.1, at l=0.977410 Å over 360°, with Df=0.25° frames and an exposure time
of 0.5 s per frame. Molecular replacement was performed using Phenix with the following search model: sagSrtA
(PDB ID: 3FN5, spySrtA). Refinement was performed using Phenix, manual refinement was done using Coot,
and model geometry was assessed using Molprobity.
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